Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: Study using Carnoy's fixation and immunohistochemistry for detection of bacteria

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 9, 2001, Pages 1485-1491

  Ishihara, S ^a   Okuyama, T ^a   Ishimura, N ^a   Ono, M ^a   Hashimoto, T ^a   Kazumori, H ^a   Kaji, T ^a   Sato, H ^a   Fujishiro, H ^a   Adachi, K ^a   Fukuda, R ^a   Kinoshita, Y ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SHORT COURSE THERAPY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH MUCUS; TISSUE DISTRIBUTION; TISSUE FIXATION;

ACETIC ACID; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; CHLOROFORM; ETHANOL; FEMALE; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER;

EID: 0034845220     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01067.x     Document Type: Article

References (24)

1. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
2. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-terns safety
3. Helicobacter pylori dose not migrate from the antrum to the corpus in response to omeprazole
4. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
5. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux esophagitis after treatment with lansoprazole
6. H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients
7. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease
8. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole in patients with in gastro-oesophageal reflux disease
9. Helicobacter 1996; Immunohistochemical detection of Helicobacter pylori in the surface mucus gel layer and its clinicopathological significance
10. Helicobacter pylori and the surface mucous gel layer of the human stomach
11. Classification and grading of gastritis - The updated Sydney system
12. Double blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers
13. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori
14. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients
15. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
16. Randomised contorolled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention
17. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs. Acid suppression trial: Ranitidine versus omeprazole for NSAIDs-associated ulcer treatment (ASTRONAUT) study group
18. Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs
19. Omeprazole and Helicobacter pylori: Temporary supression rather than true eradication
20. Omeprazole therapy for Helicobacter pylori infection
21. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal injury
22. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds
23. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole
24. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan